Bioethics News

California Drug Price Measure Fiercely Opposed By Pharmaceutical Industry

California is among about a dozen states considering proposals this year to impose greater price transparency on drug companies. The measures in many states have gone farther than Hernandez’s bill, requiring manufacturers to report their research and development costs, not just the prices and the reasons for them

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.